TY - JOUR
TI - Surgery for liver metastases from breast cancer
AU - Charalampoudis, Petros
AU - Mantas, Dimitrios
AU - Sotiropoulos, Georgios
AU - C.
AU - Dimitroulis, Dimitrios
AU - Kouraklis, Gregory
AU - Markopoulos,
AU - Christos
JO - Future oncology (London, England)
PY - 2015
VL - 11
TODO - 10
SP - 1519-1530
PB - Future Medicine Ltd
SN - null
TODO - 10.2217/fon.15.43
TODO - breast cancer; chemotherapy; hepatectomy; liver metastases;
metastasectomy; resection; survival; surgery
TODO - Introduction: Liver metastases from breast cancer (BCLM) confer poor
survival. Liver resection in BCLM patients has been increasingly
employed. Aim: We undertook a systematic review to evaluate the role of
hepatic resection in patients with breast cancer metastatic to the
liver. Materials & methods: In total, 36 studies were overviewed.
Patient populations, characteristics, morbidity, mortality and survival
were documented. Results: Median overall survival was 41 months. Major
morbidity was rare while 30-day postoperative mortality was near nil.
Conclusion: Liver surgery for BCLM can be performed with low mortality,
acceptable morbidity and promising survival benefit in carefully
selected patients.
ER -